Pharmsville팜스빌
318010 · KOSDAQ · ₩318010 · 팜스빌
₩3,345▼ ₩65 (1.91%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩13B | ₩17B | ₩21B | ₩26B | ₩39B |
| Cost of sales | ₩4.7B | ₩6.2B | ₩8.2B | ₩10B | ₩13B |
| Gross profit | ₩8.1B | ₩11B | ₩13B | ₩16B | ₩26B |
| Operating income | −₩673M | −₩258M | ₩1.6B | ₩4.1B | ₩6.2B |
| Net income | ₩2.9B | ₩1.6B | ₩3.3B | ₩4.1B | ₩2.9B |
| Net income to shareholders | ₩2.9B | ₩1.6B | ₩3.3B | ₩4.1B | ₩5B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩69B | ₩67B | ₩71B | ₩75B | ₩74B |
| Current assets | ₩41B | ₩41B | ₩44B | ₩48B | ₩49B |
| Cash and equivalents | ₩1.7B | ₩18B | ₩5.5B | ₩18B | ₩14B |
| Total liabilities | ₩2B | ₩2.5B | ₩7.3B | ₩12B | ₩15B |
| Current liabilities | ₩1.9B | ₩2.2B | ₩5.4B | ₩6.9B | ₩7.2B |
| Borrowings | — | — | ₩2.2B | ₩7.3B | ₩8B |
| Total equity | ₩67B | ₩65B | ₩64B | ₩63B | ₩59B |
| Shareholders' equity | ₩66B | ₩65B | ₩64B | ₩63B | ₩59B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩1.9B | −₩347M | ₩4.7B | ₩5.2B | ₩8.3B |
| Capital spending | ₩2.9M | ₩26M | ₩194M | ₩120M | ₩291M |
| Free cash flow | ₩1.9B | −₩373M | ₩4.5B | ₩5.1B | ₩8B |
| Dividends paid | ₩773M | ₩775M | ₩785M | ₩785M | ₩785M |
Consolidated where available. Amounts in won.
Also known as: Pharmsville / 팜스빌 / 318010 / KRX:318010
Source: KRX statistical information